Research and Markets: Global Opportunities in Development of Molecular Diagnostics Analysed.DUBLIN, Ireland -- Research and Markets has announced the addition of the revised edition of "Molecular Diagnostics: Transforming Pharmaceuticals, Impacting New Markets to their offering" The in vitro diagnostics In vitro diagnostic (IVD) tests are medical tests conducted in a test tube, or more generally in a controlled environment outside a living organism. In vitro means in glass in Latin. industry is at the forefront of far-reaching changes in healthcare. Based on a deeper understanding of the molecular basis of disease and individual differences in disease susceptibility and drug responses, molecular diagnostics will enable selection of the most effective treatment for each individual patient, initiation of treatment at an early or presymptomatic stage, and in some cases, prevention of disease altogether. This Report brings the reader up-to-date on all the intervening developments in the areas of nucleic acid nucleic acid, any of a group of organic substances found in the chromosomes of living cells and viruses that play a central role in the storage and replication of hereditary information and in the expression of this information through protein synthesis. testing and specialist immunoassays, and, in addition, covers a much wider range of platform technologies and products. There are new sections on topics such as DNA microarrays, gene expression profiling Microarray technology is often used for gene expression profiling. It makes use of the sequence resources created by the genome sequencing projects and other sequencing efforts to answer the question, , protein chips, protein expression profiling, lipidomics, and bioinformatics. The Report offers coverage of all major disease areas with an emphasis on the biggest and growing markets. In addition, expanding applications of molecular diagnostics outside the clinical field are surveyed - including veterinary, food and water testing Water Testing Water testing is used around the world on various waterways to improve the quality of the water and test how well the water is already. It is vital for many people around the water-ways and for drinking water. , and anti-counterfeiting applications. Molecular diagnostics opportunities within the top eight world markets are discussed, and profiles of key companies currently developing molecular diagnostics are included. Market Opportunities --Develop new diagnostic and predictive tests by exploiting recent technology advances in molecular analysis. --Create safer, more effective personalized treatments through the development of targeted therapies that rely upon more specific markers of disease and drug responsivenss. --Discover and develop novel companion diagnostic-drug products by capitalizing on discoveries of new molecular markers of disease and creating synergy between diagnostic and pharmaceutical industries. This report will enable readers to: --Pinpoint the full market potential of molecular diagnostics with a comprehensive examination of high-growth applications, including the biggest and most rapidly expanding therapeutic markets - communicable diseases communicable diseases, illnesses caused by microorganisms and transmitted from an infected person or animal to another person or animal. Some diseases are passed on by direct or indirect contact with infected persons or with their excretions. , cardiology, and oncology. --Gain insight into the non-clinical field of molecular diagnostics through a complete review of non-clinical applications, including veterinary, food and water, and anti-counterfeiting. --Identify viable technology drivers through a comprehensive look at various platform technologies for molecular diagnostics. --Obtain a thorough understanding of the chief molecular diagnostic tests available - predictive, screening, prognostic prog·nos·tic adj. 1. Of, relating to, or useful in prognosis. 2. Of or relating to prediction; predictive. n. 1. A sign or symptom indicating the future course of a disease. 2. , monitoring, theranostic - from an extensive study of their basic principles to their applications. --Learn about global industry developments through an in-depth analysis of the major world markets for molecular diagnostics, including forecasts for growth. --Look inside 30 companies working within molecular diagnostics, including their products and services, financial standing, M&A activity, research pipelines, and more. Contents Include: - Technology Developments - Communicable Diseases - Cardiovascular Diseases. - Cancer - Miscellaneous Diseases and Conditions - Non-Clinical Applications - Company Profiles - Trends and Opportunities Company Profiles included in this report - Abbott Laboratories Abbott Laboratories (NYSE: ABT) is a diversified pharmaceuticals and health care company. It has over 65,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, Illinois, a neighborhood of North Chicago, Illinois. Inc - Agendia BV - Bayer AG Bayer AG German chemical and pharmaceutical company. Founded in 1863 by Friedrich Bayer (1825–1880), it now operates plants in more than 30 countries. Bayer has originated scores of pharmaceuticals, chemicals, and synthetic materials; it was the first developer and - Biosite Inc - Cepheid - Chembio Diagnostic Systems Inc - Chiron Corporation Chiron Corporation was a multinational biotechnology firm based in Emeryville, California that was acquired by Novartis International AG on April 20 2006. It had offices and facilities in eighteen countries on five continents. - Ciphergen Biosystems Inc - Correlogic Systems - Diagnostic Products Corporation - DiagnoSwiss SA - Digene Corporation - Epigenomics AG - EXACT Sciences Corp - Genaissance Pharmaceuticals Inc - Gen-Probe Inc - HandyLab - Innogenetics NV - Interleukin interleukin Any of a class of naturally occurring proteins important in regulation of lymphocyte function. Several known types are recognized as crucial constituents of the body's immune system (see immunity). Genetics - Matritech Inc - Myriad Genetics Myriad Genetics is a leading biopharmaceutical company focused on understanding the relationship between genes, proteins and human diseases in order to develop the next generation of therapeutic and molecular diagnostic products. Inc - Nanogen - Nuvelo Inc - Nymox Pharmaceutical Corp - OXIS International Inc - Proteome pro·te·ome n. The complete set of proteins that are produced by the genes of an organism. proteome the entire complement of proteins produced by a cell. Sciences plc - Roche Holding Ltd - Sequenom Inc - SomaLogic Inc - Third Wave Technologies Inc For more information visit http://www.researchandmarkets.com/reports/c7596 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion